On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
"We have to rethink the sense of clinical research from the point of view that if we have the possibility to have markers that...
How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related...
How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...